Miroslava Petkova Strandzheva

Mrs. Miroslava Petkova Strandzheva

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2026 in Inorganics
Verified
Journal Article
Open access
PDF file
Petya Emilova MarinovaPetya Emilova Marinova
Petya Emilova Marinova
MSMiroslava Petkova Strandzheva
Miroslava Petkova Strandzheva
DBDenica Blazheva
Denica Blazheva
Ionut-Iulian LunguIonut-Iulian Lungu
Ionut-Iulian Lungu
Oana CioancaOana Cioanca
Oana Cioanca
ASAlina Stefanache
Alina Stefanache
The synthesis and systematic investigation of inorganic and organic compounds are fundamental to medicinal and pharmaceutical chemistry, particularly for developing novel therapeutic agents. Transition-metal complexes and bioactive organic compounds have shown significant potential to modulate cellular pathways, yielding anticancer, antimicrobial, and anti-inflammatory effects. This review summarizes recent advances in the synthesis, structural characterization, and therapeutic evaluation of gold (Au), platinum (Pt), and ruthenium (Ru) complexes, as well as selected organic compounds, with an emphasis on their biological activities and potential clinical relevance. The integration of synthetic chemistry with biological evaluation underscores the therapeutic potential of gold (Au), platinum (Pt), and ruthenium (Ru) complexes, as well as organic compounds. Au(I/III), Pt(II/IV), and Ru(II/III) complexes demonstrated notable in vivo anticancer activity, while selected organic derivatives exhibited promising bioactive properties. This review aims to support researchers and clinicians in the ongoing development of novel compounds with clinical relevance for anticancer, antimicrobial, and anti-inflammatory applications.

22 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMiroslava Petkova Strandzheva
Miroslava Petkova Strandzheva
Petya Emilova MarinovaPetya Emilova Marinova
Petya Emilova Marinova
DSDimitar Stoitsov
Dimitar Stoitsov
ASAlina Stefanache
Alina Stefanache
NBNikola Burdzhiev
Nikola Burdzhiev
MKMaria Hristova Kazakova
Maria Hristova Kazakova
The aim of this paper is to obtain and verify the structures and the biological activity of novel metal complexes derived from 5-carboxy-2-thiouracil. The paper outlines a synthesis method and assesses the antimicrobial activity of newly formed Cu(II), Ni(II) and Co(II) complexes. Several syntheses were carried out with and without NaOH. The structural were verified by melting point analysis, ICP-OES for Cu, Ni and Co, UV-Vis, ATR, solid state and solution 1H NMR, 13C NMR spectroscopy. In addition, the antimi-crobial activity of these complexes and the free ligand are assessed against both Gram-positive and Gram-negative bacteria, as well as yeasts. For the cytotoxic assay we were used the HCT-116 colorectal cell line (ATCC). Only two Ni(II) complexes show reduction in the number of viable tumor cells. All the other compounds did not lead to a significant reduction in the number of viable cells as determined by one-way ANOVA statistical analysis.

6 November 2026 in Processes
Verified
Journal Article
Open access
PDF file
MSMiroslava Petkova Strandzheva
Miroslava Petkova Strandzheva
Petya Emilova MarinovaPetya Emilova Marinova
Petya Emilova Marinova
DSDimitar Stoitsov
Dimitar Stoitsov
ASAlina Stefanache
Alina Stefanache
NBNikola Burdzhiev
Nikola Burdzhiev
MKMaria Hristova Kazakova
Maria Hristova Kazakova
In this paper, we describe and verify the structures and biological activity of novel metal complexes derived from 5-carboxy-2-thiouracil. We outline a synthesis method and assess the antimicrobial activity of newly formed Cu(II), Ni(II) and Co(II) complexes. Several syntheses were carried out with and without NaOH. The structures were verified using melting point analysis, MP-AES for Cu, Ni and Co and ICP-OES for sulfur, UV-Vis, ATR, solid-state and solution 1H NMR, 13C NMR spectroscopy. In addition, the antimicrobial activity of these complexes and the free ligand were assessed against both Gram-positive and Gram-negative bacteria, as well as yeasts. The HCT-116 colorectal cell line (ATCC) was used for a cytotoxic assay. Only two Ni(II) complexes showed reduction in the number of viable tumor cells. None of the other compounds led to a significant reduction in the number of viable cells, as determined by one-way ANOVA statistical analysis.